25228 Federal Register / Vol. 61, No. 98 / Monday, May 20, 1996 / Notices

attachments may be formatted as

WordPerfect 5.0, 5.1/5.2, 6.0/6.1, or

ASCII files.

Information can also be obtained by

calling 1–800–35–NIOSH or by the

Internet NOISH Homepage: http:/

www.cdc.gov/noish/homepage.html.

Dated: May 14, 1996.

Nancy C. Hirsch,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–12557 Filed 5–17–96; 8:45 am]

BILLING CODE 4160–19–M

Food and Drug Administration

[Docket No. 96F–0145]

Albright & Wilson, Ltd.; Filing of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Albright & Wilson, Ltd., has filed a

petition proposing that the food additive

regulations be amended to provide for

the safe use of

tetrakis(hydroxymethyl)phosphonium

sulfate as a slimicide for use in the

manufacture of paper and paperboard

intended to contact food.

DATES: Written comments on the

petitioner’s environmental assessment

by June 19, 1996.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Daniel N. Harrison, Center for Food

Safety and Applied Nutrition (HFS–

216), Food and Drug Administration,

200 C St. SW., Washington, DC 20204–

0002, 202–418–3080.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 5B4472) has been filed by

Albright & Wilson, Ltd., c/o Delta

Analytical Corp., 7910 Woodmont Ave.,

suite 1000, Bethesda, MD 20814. The

petition proposes to amend the food

additive regulations in § 176.300

Slimicides (21 CFR 176.300) to provide

for the safe use of

tetrakis(hydroxymethyl)phosphonium

sulfate as a slimicide in the manufacture

of paper and paperboard intended to

contact food.

The potential environmental impact

of this action is being reviewed. To

encourage public participation

consistent with regulations promulgated

under the National Environmental

Policy Act (40 CFR 1501.4(b)), the

agency is placing the environmental

assessment submitted with the petition

that is the subject of this notice on

public display at the Dockets

Management Branch (address above) for

public review and comment. Interested

persons may, on or before June 19, 1996,

submit to the Dockets Management

Branch (address above) written

comments. Two copies of any comments

are to be submitted, except that

individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday. FDA will also

place on public display any

amendments to, or comments on, the

petitioner’s environmental assessment

without further announcement in the

Federal Register. If, based on its review,

the agency finds that an environmental

impact statement is not required and

this petition results in a regulation, the

notice of availability of the agency’s

finding of no significant impact and the

evidence supporting that finding will be

published with the regulation in the

Federal Register in accordance with 21

CFR 25.40(c).

Dated: April 30, 1996.

Alan M. Rulis,

Director, Office of Premarket Approval,

Center for Food Safety and Applied Nutrition.

[FR Doc. 96–12568 File6d 5–17–96; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 93F–0152]

Witco Corp.; Withdrawal of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

withdrawal, without prejudice to future

filing, of a food additive petition (FAP

3B4348), filed by Witco Corp. proposing

that the food additive regulations be

amended to provide for the safe use of

decanedioic acid, polymer with 1,2-

ethanediamine, (Z,Z)-9,12-

octadecadienoic acid dimer and 4,4′-

(1,3-propaneidyl) bis (piperidine) as a

polymer coating onaluminum foil,

polyolefin film, and paper and

paperboard and as an adhesive, for use

in contact with food.

FOR FURTHER INFORMATION CONTACT:

Hortense S. Macon, Center for Food

Safety and Applied Nutrition (HFS–

216), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3086.

SUPPLEMENTARY INFORMATION: In a notice

published in the Federal Register of

May 19, 1993 (58 FR 29231), FDA

announced that a food additive petition

(FAP 3B4348) had been filed by Witco

Corp., 5777 Frantz Rd., P.O. Box 646,

Dublin, OH 43017. The petition

proposed to amend the food additive

regulations to provide for the safe use of

decanedioic acid, polymer with 1,2-

ethanediamine, (Z,Z)-9,12-

octadecadienoic acid dimer and 4,4′-

(1,3-propaneidyl) bis (piperidine) as a

polymer coating on aluminum foil,

polyolefin film, and paper and

paperboard and as an adhesive, for use

in contact with food. Witco Corp. has

now withdrawn the petition without

prejudice to a future filing (21 CFR

171.7).

Dated: April 30, 1996.

Alan M. Rulis,

Director, Office of Premarket Approval,

Center for Food Safety and Applied Nutrition.

[FR Doc. 96–12567 Filed 5–17–96; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 96N–0151]

SmithKline Beecham Pharmaceuticals;

Withdrawal of Approval of a New Drug

Application for Selacryn Tablets

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is withdrawing

approval of a new drug application

(NDA) for Selacryn (ticrynafen)

Tablets held by SmithKline Beecham

Pharmaceuticals (Smithkline).

SmithKline requested that the NDA be

withdrawn because the product is no

longer being marketed. SmithKline also

waived its opportunity for a hearing.

EFFECTIVE DATE: May 20, 1996.

FOR FURTHER INFORMATION CONTACT: Lola

E. Batson, Center for Drug Evaluation

and Research (HFD–7), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1038.

SUPPLEMENTARY INFORMATION: By letter

dated June 30, 1994, SmithKline, Four

Falls Corp. Center, Route 23 and

Woodmont Ave., P.O. Box 1510,

FF0410, King of Prussia, PA 19406,

requested that FDA withdraw NDA 18–

103 for Selacryn (ticrynafen) Tablets,

stating that the company discontinued